Statins may raise stroke risk in some: study

	Tweet

People who have had a type of stroke caused by bleeding in the brain should avoid taking cholesterol-lowering drugs known as Statins, U.S. researchers said on Monday.

Although Statins are commonly used to prevent heart attacks and strokes, they said the drugs could increase the risks of a second stroke in these patients, outweighing any other heart benefits from the drugs.

“Our analysis indicates that in settings of high recurrent intracerebral hemorrhage risk, avoiding statin therapy may be preferred,” Dr. Brandon Westover of Massachusetts General Hospital and Harvard Medical School and colleagues wrote in the Archives of Neurology.

That was especially true of people who had strokes in one of the brain’s four lobes - frontal, parietal, temporal, or occipital - which recur more frequently than such strokes that occur deep in the brain.

Westover said people who have had this type of stroke have a 22 percent risk of a second stroke when they take Statins, compared with a 14 percent risk in people who are not taking a statin.

The findings are based on a mathematical model based on data from two clinical trials.

The researchers said it is not clear how Statins increase the bleeding risk in these patients. It may be having low cholesterol increases the risk of bleeding in the brain, or it may be that Statins affect clotting factors in the blood that increase the risk of a brain hemorrhage in these patients.

Statins lower low-density lipoprotein or LDL, the bad kind of cholesterol that can lead to blood clots that increase the risk of heart attacks and strokes.

They are among the best-selling drugs in the world, fueled by many studies showing they reduce the risk of heart attacks and strokes.

Dr. Larry Goldstein of Duke University and Durham VA Medical Center in North Carolina said in a commentary the findings do not prove that Statins increase the risk. But he said in the absence of high-quality clinical trial data, they may help doctors make better decisions about which patients with heart risks will benefit from taking Statins.

Coronary heart disease is the leading cause of death in the United States, killing one in five adults.

Pfizer’s Lipitor or atorvastatin has global sales of $11 billion a year while AstraZeneca’s Crestor has global sales of more than $5 billion.

SOURCE: Archives of Neurology, online January 10, 2011.

RELATED STORIES:
Stroke rate 25 percent higher for Metis   Stroke Survivors Improve Balance with Tai Chi   Acute anemia linked to silent strokes in children   Study finds soda consumption increases overall stroke risk   Stroke awareness campaign aims to halve deaths   Studies on heart disease and stroke prevention overlook ethnic groups: Study   Many don’t seek prompt help after ‘mini-stroke’   Exposure to Several Common Infections Over Time May Be Associated With Risk of Stroke   Internal Body Clock Dictates Timing of Different Types of Stroke   Estrogen and Stroke Risk   High Triglycerides, Other Cholesterol Raise Risk of Stroke   Patient Makes Dramatic Recovery From Stroke

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]